https://www.tersanpharm.com/arianas-kem-analysis-shows-positive-impact-on-patient-quality-of-life-for-valiseek-val401-in-phase-ii-trial-for-nsclc-patients/?utm_source=rss&utm_medium=rss&utm_campaign=arianas-kem-analysis-shows-positive-impact-on-patient-quality-of-life-for-valiseek-val401-in-phase-ii-trial-for-nsclc-patients The AI DRUG Development Company Tue, 14 Dec 2021 19:03:47 +0000 hourly 1 https://wordpress.org/?v=5.8.2